HealthCap
HealthCap is a European venture capital firm specializing in life sciences, with a focus on investing in breakthrough therapies for diseases with high unmet medical needs. Since its founding in 1996, HealthCap has raised eight funds and has been instrumental in backing and building over 130 companies, leading to more than 45 public offerings and numerous trade sales. The firm is dedicated to fostering innovation in healthcare, aiming to make a significant impact on patient outcomes and societal health.
HealthCap
Engelbrektsplan 1, 114 34 Stockholm, Sweden
Portfolio
Aprea Therapeutics is exploring APR-1051 as a potential treatment for head and neck squamous cell carcinoma.
#Biotechnology
HelloBetter secured over €6 million to accelerate international expansion and AI development.
#Digital Health
Hemab Therapeutics announced the start of a Phase 1/2 clinical trial for HMB-002 for the treatment of Von Willebrand Disease.
#Biotechnology